Royalty Pharma Plc Cl A (RPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1999 | 12-1998 | 12-1997 | 12-1996 | 12-1995 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,952 | -12,310 | -13,173 | -9,470 | -4,287 |
| Depreciation Amortization | 408 | 350 | 383 | 350 | 317 |
| Accounts receivable | -86 | 0 | 0 | 0 | 0 |
| Other Working Capital | -1,677 | -4,190 | 3,682 | 760 | 607 |
| Other Operating Activity | -689 | 480 | 853 | 370 | 114 |
| Operating Cash Flow | $-13,996 | $-15,670 | $-8,255 | $-7,990 | $-3,249 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -35,030 | 0 | 0 | 0 | 0 |
| PPE Investments | 1,939 | -570 | -367 | -180 | -44 |
| Other Investing Activity | -521 | -100 | -301 | -200 | -133 |
| Investing Cash Flow | $-33,612 | $-670 | $-668 | $-380 | $-177 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 75 | 0 | 0 | 0 | 0 |
| Other Financing Activity | -1 | -5,760 | 71,611 | 15,260 | 5,168 |
| Financing Cash Flow | $74 | $-5,760 | $71,611 | $15,260 | $5,168 |
| Beginning Cash Position | 51,640 | 73,760 | 11,075 | 4,190 | 2,448 |
| End Cash Position | 4,106 | 51,640 | 73,762 | 11,070 | 4,190 |
| Net Cash Flow | $-47,534 | $-22,120 | $62,687 | $6,880 | $1,742 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,996 | -15,670 | -8,255 | -7,990 | -3,249 |
| Capital Expenditure | -311 | 0 | 0 | 0 | 0 |
| Free Cash Flow | -14,307 | -15,670 | -8,255 | -7,990 | -3,249 |